688131 皓元医药
2026/09 - 九个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额295,335317,749381,960(63,606)(240,233)
投资活动产生之现金流量净额(104,153)(202,043)(783,654)(328,511)(713,002)
筹资活动产生之现金流量净额72,163177,002791,479409,209360,324
汇率变动对现金及现金等价物的影响(66,155)(1,084)7,8453,11114,415
现金及现金等价物净增加/(减少)197,189291,624397,63020,202(578,496)
期初现金及现金等价物余额1,164,720873,096475,466455,2641,033,760
期末现金及现金等价物余额1,361,9091,164,720873,096475,466455,264